SCHEMBL14697635

SCHEMBL14697635

NC1CNC(=O)C1=O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1687039 0.73
SCHEMBL2489118 0.73
SCHEMBL7443022 0.73
Hydrochloric Acid SCHEMBL29001926 0.71
Hydrochloric Acid SCHEMBL11390402 0.71
Hydrochloric Acid SCHEMBL29001924 0.71
SCHEMBL19345911 0.70 L3MBTL1 (0.32)
SCHEMBL12801948 0.67
SCHEMBL13976324 0.67
Sulfuric Acid SCHEMBL1686757 0.65 BLM (0.36)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9540358-B2 Tricyclic compounds as anticancer agents ICAHN SCHOOL OF MEDICINE AT MOUNT SINAI (US) 2017-01-10 US disclosed
US-20140213578-A1 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS MT. SINAI SCHOOL OF MEDICINE (US) 2014-07-31 US disclosed
EP-2744808-A2 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS Mount Sinai School of Medicine (US) 2014-06-25 EP disclosed
WO-2013025882-A2 TRICYCLIC COMPOUNDS AS ANTICANCER AGENTS MT. SINAI SCHOOL OF MEDICINE (US) 2013-02-21 WO disclosed